IL-8

IL-8 詳細

英語名Interleukin-8市販薬剤の数1
治験薬の数6ターゲットの別称IL8/NAP1 form VI,T-cell chemotactic factor,GCP/IL-8 protein III,IL8/NAP1 form II,GCP/IL-8 protein II,(Ala-IL-8)77,Emoctakin,IL8/NAP1 form IV,LYNAP,IL8/NAP1 form III,IL8/NAP1 form V,GCP/IL-8 protein I,Neutrophil-Activating Peptide 1,Interleukin 8,GCP-1,MDNCF,NAP-1,IL8,Beta Endothelial Cell-Derived Neutrophil Activating Peptide,Lung Giant Cell Carcinoma-Derived Chemotactic Protein,Lymphocyte Derived Neutrophil Activating Peptide,Alveolar Macrophage Chemotactic Factor I,Tumor Necrosis Factor-Induced Gene 1,Small Inducible Cytokine Subfamily B, Member 8,Beta-Thromboglobulin-Like Protein,GCP1,LECT,LUCT,NAP1,IL-8,Interleukin-8,AMCF-I,SCYB8,Neutrophil-Activating Protein 1,B-ENAP,3-10C,K60,TSG-1,C-X-C Motif Chemokine Ligand 8,Monocyte-Derived Neutrophil Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Granulocyte Chemotactic Protein 1,Chemokine (C-X-C Motif) Ligand 8,(Ser-IL-8)72,Neutrophil-activating factor,MDNCF-c,C-X-C motif chemokine 8,Lymphocyte-derived neutrophil-activating factor,Protein 3-10C,IL-8(1-77),NAF,GCP/IL-8 protein VI,GCP/IL-8 protein IV,IL8/NAP1 form I,MONAP,MDNCF-b,GCP/IL-8 protein V,CXCL8
研究&開発段階Approved
英語名Interleukin-8
ターゲットの別称IL8/NAP1 form VI,T-cell chemotactic factor,GCP/IL-8 protein III,IL8/NAP1 form II,GCP/IL-8 protein II,(Ala-IL-8)77,Emoctakin,IL8/NAP1 form IV,LYNAP,IL8/NAP1 form III,IL8/NAP1 form V,GCP/IL-8 protein I,Neutrophil-Activating Peptide 1,Interleukin 8,GCP-1,MDNCF,NAP-1,IL8,Beta Endothelial Cell-Derived Neutrophil Activating Peptide,Lung Giant Cell Carcinoma-Derived Chemotactic Protein,Lymphocyte Derived Neutrophil Activating Peptide,Alveolar Macrophage Chemotactic Factor I,Tumor Necrosis Factor-Induced Gene 1,Small Inducible Cytokine Subfamily B, Member 8,Beta-Thromboglobulin-Like Protein,GCP1,LECT,LUCT,NAP1,IL-8,Interleukin-8,AMCF-I,SCYB8,Neutrophil-Activating Protein 1,B-ENAP,3-10C,K60,TSG-1,C-X-C Motif Chemokine Ligand 8,Monocyte-Derived Neutrophil Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Granulocyte Chemotactic Protein 1,Chemokine (C-X-C Motif) Ligand 8,(Ser-IL-8)72,Neutrophil-activating factor,MDNCF-c,C-X-C motif chemokine 8,Lymphocyte-derived neutrophil-activating factor,Protein 3-10C,IL-8(1-77),NAF,GCP/IL-8 protein VI,GCP/IL-8 protein IV,IL8/NAP1 form I,MONAP,MDNCF-b,GCP/IL-8 protein V,CXCL8
市販薬剤の数1
治験薬の数6
研究&開発段階Approved

IL-8 製品リスト

  • 属性

    Protein (5)Kits (3)

  • 製品ライブラリ

    オンライン (7)研究中 (1)

  • Human (7)Rhesus macaque (1)

  • タグ

    His Tag (2)Fc Tag (1)His Tag & Avi Tag (1)- (3)Tag Free (1)

  • マーカー

    Unconjugated (4)Biotin-labeled (1)- (3)

IL-8バックグランド

Interleukin 8 (IL8 or chemokine (C-X-C motif) ligand 8, CXCL8) is a chemokine produced by macrophages and other cell types such as epithelial cells, airway smooth muscle cells and endothelial cells. There are many receptors on the surface membrane capable of binding IL-8, the most frequently studied types are the G protein-coupled serpentine receptors CXCR1 and CXCR2. Expression and affinity for IL-8 differs between the two receptors (CXCR1 > CXCR2). IL-8(6-77) has a 5-10-fold higher activity on neutrophil activation, IL-8(5-77) has increased activity on neutrophil activation and IL-8(7-77) has a higher affinity to receptors CXCR1 and CXCR2 as compared to IL-8(1-77), respectively.

IL-8分子の別称

CXCL8,GCP1,IL8,LECT,LUCT,LYNAP,MDNCF,MONAP,NAF,NAP-1

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
EnsereptidePXL-01Phase 3 ClinicalPromore PharmaCicatrix; Post-surgical adhesions; Tissue Adhesions
詳細
CinainuPhase 3 ClinicalLegacy Healthcare (Switzerland) SaAlopecia Areata
詳細
Sodium HypochloritePhase 3 ClinicalCystic Fibrosis; Dental Pulp Necrosis; Fibrosis; Infections; Pain; Pain, Postoperative; Pulpitis
詳細
AdakitugBMS-986253; MDX-018Phase 2 ClinicalBristol-Myers Squibb Company, Genmab A/S, Medarex IncCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Coronavirus Disease 2019 (COVID-19); Hematologic Neoplasms; Melanoma; Myelodysplastic Syndromes; Neoplasms; Prostatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
AMY-109AMY-109; AMY109Phase 2 ClinicalChugai Pharmaceutical Co LtdEndometriosis; Solid tumours
詳細
AC-701AC-701Phase 2 ClinicalTwi Pharmaceuticals IncExanthema; Rosacea
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Mouse monoclonal antibody against human interleukin-8 creamApprovedDalian Asia Space Pharmaceutical Co Ltd, Dongguan Hongyuan Yishi Biotechnology Pharmaceutical Co Ltd恩博克Mainland ChinaEczema; PsoriasisDalian Asia Space Pharmaceutical Co Ltd2001-04-10Eczema; Psoriasis
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8